dextrothyroxine has been researched along with molnupiravir in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 3 (100.00) | 2.80 |
Authors | Studies |
---|---|
Tsanni, A | 1 |
Atal, S; Kaore, S | 1 |
Bates, DW; Hua, Y; Jiang, H; Lin, S; Plasek, JM; Yang, J; Zhou, L | 1 |
1 review(s) available for dextrothyroxine and molnupiravir
Article | Year |
---|---|
Molnupiravir in COVID-19: A Scoping Review.
Topics: Adrenal Cortex Hormones; Animals; Antiviral Agents; COVID-19 Drug Treatment; Cricetinae; Ferrets; Humans; Hydroxychloroquine; Ivermectin; Lopinavir; Mice; Ritonavir; RNA-Dependent RNA Polymerase; SARS-CoV-2 | 2022 |
2 other study(ies) available for dextrothyroxine and molnupiravir
Article | Year |
---|---|
African scientists race to test COVID drugs - but face major hurdles.
Topics: Africa; Amides; Amodiaquine; Artesunate; Atazanavir Sulfate; Carbamates; Clinical Trials as Topic; COVID-19; COVID-19 Drug Treatment; COVID-19 Vaccines; Cytidine; Drug Approval; Drug Evaluation, Preclinical; Drug Repositioning; Drug Therapy, Combination; Humans; Hydroxylamines; Imidazoles; Ivermectin; Naphthyridines; Nitro Compounds; Pregnenediones; Pyrazines; Pyrrolidines; Ritonavir; Sample Size; Thiazoles; Valine; World Health Organization | 2021 |
Using Twitter data to understand public perceptions of approved versus off-label use for COVID-19-related medications.
Topics: COVID-19 Drug Treatment; Cytidine; Delivery of Health Care; Humans; Hydroxychloroquine; Hydroxylamines; Ivermectin; Off-Label Use; Pandemics; Public Opinion; Retrospective Studies; Social Media | 2022 |